Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| 1 |
Intuitive Surgical
ISRG
|
$1.04B |
| 2 |
Moderna
MRNA
|
$903M |
| 3 |
Charles Schwab
SCHW
|
$631M |
| 4 |
Affirm
AFRM
|
$556M |
| 5 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
$514M |
Top Sells
| 1 |
Tesla
TSLA
|
$3.23B |
| 2 |
Full Truck Alliance
YMM
|
$995M |
| 3 |
ResMed
RMD
|
$718M |
| 4 |
NVIDIA
NVDA
|
$691M |
| 5 |
Amazon
AMZN
|
$509M |
Sector Composition
| 1 | Consumer Discretionary | 26.58% |
| 2 | Healthcare | 23.23% |
| 3 | Technology | 21.05% |
| 4 | Communication Services | 12.81% |
| 5 | Financials | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
FTCH
51
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $1.02B | 0.56% | 30,400,596 +15,383,872 | +102% | +$514M |
|
52
Teladoc Health
TDOC
$1.37B
| $999M | 0.55% | 10,877,063 +2,071,756 | +24% | +$190M |
|
53
Thermo Fisher Scientific
TMO
$186B
| $995M | 0.55% | 1,491,092 -6,174 | -0.4% | -$4.12M |
|
54
Salesforce
CRM
$245B
| $961M | 0.53% | 3,780,971 -1,310,160 | -26% | -$333M |
|
|
FRC
55
DELISTED
First Republic Bank
FRC
| $942M | 0.52% | 4,563,102 -352,895 | -7% | -$72.9M |
|
56
Mettler-Toledo International
MTD
$26.8B
| $913M | 0.5% | 538,094 -11,643 | -2% | -$19.8M |
|
57
Ginkgo Bioworks
DNA
$750M
| $910M | 0.5% | 109,450,171 +18,447,361 | +20% | +$153M |
|
58
SiteOne Landscape Supply
SITE
$6.39B
| $905M | 0.5% | 3,734,592 -4,319 | -0.1% | -$1.05M |
|
59
S&P Global
SPGI
$167B
| $891M | 0.49% | 1,889,039 +401 | +0% | +$189K |
|
60
TSMC
TSM
$1.2T
| $887M | 0.49% | 7,376,122 -32,456 | -0.4% | -$3.9M |
|
61
Roku
ROKU
$14.2B
| $832M | 0.46% | 3,644,405 -9,044 | -0.2% | -$2.06M |
|
62
Booking.com
BKNG
$181B
| $826M | 0.45% | 344,195 +438 | +0.1% | +$1.05M |
|
63
Chewy
CHWY
$16.9B
| $784M | 0.43% | 13,302,667 +5,455,428 | +70% | +$322M |
|
64
Broadridge
BR
$29.9B
| $757M | 0.42% | 4,139,707 +57,001 | +1% | +$10.4M |
|
65
MarketAxess Holdings
MKTX
$6.87B
| $723M | 0.4% | 1,758,918 +4,404 | +0.3% | +$1.81M |
|
66
Axon Enterprise
AXON
$58.7B
| $722M | 0.4% | 4,598,695 +60,037 | +1% | +$9.43M |
|
67
NovoCure
NVCR
$1.38B
| $722M | 0.4% | 9,615,168 +245,463 | +3% | +$18.4M |
|
68
Alibaba
BABA
$322B
| $699M | 0.38% | 5,880,538 -4,096,750 | -41% | -$487M |
|
69
Denali Therapeutics
DNLI
$2.23B
| $672M | 0.37% | 15,056,381 +46,565 | +0.3% | +$2.08M |
|
70
Zillow
Z
$20.4B
| $658M | 0.36% | 10,303,636 +1,706,141 | +20% | +$109M |
|
71
Watsco
WSO
$16.3B
| $653M | 0.36% | 2,086,034 +43,878 | +2% | +$13.7M |
|
|
72
Charles Schwab
SCHW
$174B
| $631M | 0.35% | +7,506,268 | New | +$631M |
|
73
Chegg
CHGG
$159M
| $584M | 0.32% | 19,009,007 +507,662 | +3% | +$15.6M |
|
74
Baidu
BIDU
$32.8B
| $555M | 0.3% | 3,728,688 -113,936 | -3% | -$17M |
|
75
Beyond Meat
BYND
$192M
| $552M | 0.3% | 8,471,482 -87,789 | -1% | -$5.72M |
|